STAAR Surgical Company Common Stock (STAA) Stock
Key stats
- Market cap
- $1.34B
- Price / Earnings ratio
- 2260.9x
- EPS (TTM)
- $0.01
- Volume
- Loading
- 52-week high
- $35.87
- 52-week low
- $15.59
Source: third-party data provider, as of November 13, 2026
Compare with STAA
Recent news

STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
STAA

Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
STAA

STAAR Surgical to Participate in Upcoming Investor Conferences
STAAR Surgical to Participate in Upcoming Investor Conferences
STAA

STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
STAA
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 62.26
- MACD 12/26/9
- 0.88
- EMA 9 of MACD
- 0.78
- MACD histogram
- 0.11
- SMA 50
- $22.84
- Price above SMA 50
- EMA 50
- $23.67
- Price above EMA 50
- SMA 200
- $23.82
- Price above SMA 200
- EMA 200
- $23.65
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
STAA

Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
STAA

STAAR Surgical to Participate in Upcoming Investor Conferences
STAAR Surgical to Participate in Upcoming Investor Conferences
STAA

STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
STAA

STAAR Surgical Names Andrew Pilon as Vice President of Business Development
STAAR Surgical Names Andrew Pilon as Vice President of Business Development
STAA

Why Staar Surgical Zoomed Almost 8% Higher on Tuesday
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday
STAA

Why Staar Surgical Stock Soared Today
Why Staar Surgical Stock Soared Today
STAA

STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
STAA

STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
STAA

STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
STAA
News tone: automated (AI) classification of the article's content, not a price prediction.
About STAAR Surgical Company Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Warren Foust | CEO, President & Director | 1976 |
| Ms. Deborah J. Andrews | Executive VP & CFO | 1957 |
| Dr. Magda Michna Ph.D. | Chief Development Officer | — |
| Dr. Ben Park Ph.D. | Chief Technology Officer | — |
| Ms. Connie Johnson | Director of Investor Relations | — |
| Ms. Kathleen Determann J.D. | VP, Deputy General Counsel and Chief Compliance & Privacy Officer | — |
| Dr. Scott D. Barnes M.D. | Chief Medical Officer | 1963 |
| Mr. Filip De Keersmaecker | Chief Supply Chain & Quality Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 62.26
- MACD 12/26/9
- 0.88
- EMA 9 of MACD
- 0.78
- MACD histogram
- 0.11
- SMA 50
- $22.84
- Price above SMA 50
- EMA 50
- $23.67
- Price above EMA 50
- SMA 200
- $23.82
- Price above SMA 200
- EMA 200
- $23.65
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $19.00
- Average
- $24.33
- High
- $31.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -15.0 | +1.5 | ||||||||||
| 2022 | -22.2 | +7.0 | -1.2 | -29.1 | +9.9 | +8.8 | +11.8 | +16.3 | -23.1 | -0.9 | -22.6 | -17.9 |
| 2023 | +37.7 | -24.1 | +12.8 | +12.1 | -20.3 | -9.0 | +4.6 | -17.9 | -6.7 | +5.6 | -27.6 | -5.4 |
| 2024 | -5.8 | +8.9 | +14.9 | +17.7 | -7.1 | +14.8 | -13.0 | -17.2 | +14.9 | -19.2 | +1.9 | -12.4 |
| 2025 | +0.4 | -25.1 | +7.0 | +3.8 | -2.9 | +0.5 | +5.3 | +54.1 | -3.1 | -4.8 | +5.1 | -10.9 |
| 2026 | -19.7 | +10.3 | -1.8 | +36.4 | +9.9 | -2.9 | -13.5 | -7.2 | -3.9 | +9.7 | -4.3 |



